⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Surgin Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Surgin Inc.
↗Scottsdale, Arizona, USA
Surgin Inc. is a specialized medical device company focused on the development, manufacturing, and commercialization of innovative surgical instrumentation. The company serves various medical specialties, including ophthalmology, laparoscopy, colorectal surgery, gynecologic oncology, and pelvic health.
Known for its B2B model, Surgin brings medical device concepts from initial design to market availability. Its product portfolio includes specialized tools such as the Hemorrhage Occluder Pin, Releve vaginal splint, and DoseRite applicator systems. The company emphasizes surgeon-driven innovation and maintains a focus on intellectual property and patent protection for its proprietary surgical technologies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:1981
Ownership:private
Status:operating
FUNDING
Total Raised:$0M
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Surgical instrumentation, Topical drug delivery
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Dr. Jeffrey W. Milsom (Weill Cornell Medicine) - Co-developer of the Hemorrhage Occluder Pin
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Armand Maaskamp - Founder & CEO
Scientific Founders:Armand Maaskamp
LINKS
Website:surgin.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Surgin Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.